Program

Thursday, 7th October, 2010
Time Session Topic Speaker Organization
08:00~09:00 Registration
09:00~09:10
Open remark
(Auditorium)
Welcome speech
Kenneth K.Y. WU
National Health Research Institute
09:10~09:50 Keynote Speech I
(Auditorium)
Design of glycoprotein vaccines against influenza and other viral diseases
Chi-Huey Wong Academia Sinica
09:50~10:00 refreshment Refreshment
10:00~10:35 Section 1
Vaccinology
(Auditorium)
Vaccinomics: will it be the second golden age of vaccinology
Michel Klein Chairman VaxiBio Inc, Canada, Visiting Scholar, NHRI
10:35~11:10
A tale of two vaccines on "how the times they are changing"
Ian Gust The University of Melbourne
11:10~11:45
Delivery of siRNA and vaccine for cancer therapy
Leaf Huang University of North Carolina, USA
11:45~12:20
Strategic vaccine approaches for respiratory syncytial virus
Barney S. Graham National Institutes of Health
12:20~13:30 dish Lunch
13:30~14:00 Section 2
Pandemic Flu Vaccine
(Auditorium)
The development of a cell-based flu vaccine
Chia-Hsin Hsiao National Health Research Institute
14:00~14:30
Challenges for H1N1 vaccine production in 2009
Ching-Chuan, Chang Adimmune Corporation
14:30~15:00
Development of Panvax® for pandemic influenza
Russell Basser CSL Limited
15:00~15:15 refreshment Refreshment
15:15~17:15
Parallel section 3A
(Meeting room #2)
Selected poster oral presentation Attachment I.
15:15~15:45
Parallel section 3B
Workshop I
Upstream
(Meeting room #3)
Screening of cell substrates: development of new assays to detect endogenous, latent and adventitious viral contaminants
Martin Wisher BioReliance
15:45~16:15 Integrated solutions - Platform concepts for biopharmaceutical processes
Michael Koch Sartorius
16:15~17:45
Single use concept and new development for bioreactor
Thorsten Adams Sartorius
17:45~18:15
Single use concept and new development for media and buffer preparation
Mathias Bayru Sartorius
17:15~18:15 Poster section Attachment II.
18:15~ dish Welcome Reception Dinner
Friday, 8th October, 2010
Time Session Topic Speaker Organization
08:50~09:00Poster Award Presentation Ceremony (Auditorium)
09:00~09:40 Keynote Speech II
(Auditorium)
Old wine in a new bottle: Killed oral cholera vaccines
John D. Clemens International Vaccine Institute
9:40~10:10

Section 4
Emerging Diseases
(Auditorium)

Involvement of host and viral factors for interaction of PSGL-1 with enterovirus 71
Hiroyuki Shimizy National Institute of Infectious. Diseases
10:10~10:40
Scavenger receptor B2: a cellular receptor for enterovirus 71
Satoshi Koike Tokyo Metropolitan Organization for Med. Res.
10:40~11:10
Lessons from enterovirus 71 epidemics: evolution of re-emergent viruses and its impact
Jen-Ren Wang National Cheng Kung University
11:10~11:20 refreshment Refreshment
11:20~11:50 Section 5
Novel Vaccines
(Auditorium)
Innovation and strategic alliances - foundation for biotech success
Katherine Cohen Intercell
11:50~12:20
Hydrogel-delivered GM-CSF overcomes non-responsiveness to hepatitis B vaccine through recruitment and activation of dendritic cells
Mi-Hua Tao Academia Sinica
12:20~12:50
Mucosal delivery of human respiratory syncytial virus vaccine
Yen-Hung Chow National Health Research Institute
12:50~13:50 dish Lunch
13:50~14:20 Parallel section 6A
Adjuvants & delivery Systems
(Meeting room #2)
Development of micro-encapsulation technology for a single-dose multivalent vaccine against influenza and enterovirus 71
Ming-Hsi Huang National Health Research Institute
14:20~14:50
New adjuvants to fine-tune responses to mucosal vaccines
Carlos Alberto Guzman Helmholtz Center for Infection Research
14:50~15:20
A novel technology for the production of heterologous lipidated immunogens in high yield has implications for the field of vaccine design
Chih-Hsiang Leng National Health Research Institute
13:50~14:20
Parallel section 6B
Workshop II
Downstream
(Meeting room #3)
Evaluating platform technologies for vaccine purification processes
Annelies Onraedt Pall Corporation
14:20~14:50 Process economics for vaccine manufacturing
Robert Morenweiser GE Healthcare Life Sciences
14:50~15:20
Evaluating platform technologies in downstream purification for vaccine manufacturing processes
Suma Ray Sartorius
15:20~15:40 refreshment Refreshment
15:20~16:10 Parallel section 7A
Vectors
(Meeting room #2)
JEV-based vaccine development
Ching-Len Liao National Defense Medical Center
16:10~16:40
Combination of recombinant adenovirus vector and soluble HA mimetic protein to develop a "prime-boost" type H5N1 vaccine
Suh-Chin Wu
National Tsing Hua University
16:40~17:10
Alphavirus replicon particles expressing hemagglutinin and fusion proteins provide complete protection from measles
Chien-Hsiung Pan National Health Research Institute
15:40~16:10
Parallel section 7B
Workshop III
Quality Management
(Meeting room #3)
General considerations for clinical trials of vaccines/biological products
Ming-Hsiao Chan Center for Drug Evaluation, Taiwan
16:10~16:40 Revision of PIC/S GMP Annex 2 (From Premises and Equipment perspective)
Frank Wu UBI-Asia
16:40~17:10
Using label-free bioanalytics to improve vaccine development and manufacturing QA/QC
Fredrik Sundberg GE Healthcare Life Sciences

2010.09.14
National Health Research Institutes. 35, Keyan Road, Zhunan Town, Miaoli County 350, Taiwan
Tel: +886-37-246-166   ext: 37959   Fax: +886-37-246-166 ext. 37841   Attn: Sonya Tsai E-mail: vrdc@nhri.org.tw
© 2019, National Health Research Institutes. All rights reserved. (最佳瀏覽環境 1680 × 1050 適用 Firefox, Safari, Opera, Google Chrome, IE 8)